liver cancer treatment

Syndicate content

Long-term L-carnitine supplementation prevents development of liver cancer

A study will be published on March 21, 2009 in World Journal of Gastroenterology addresses the question. A research group in King Saud University, Kingdom of Saudi Arabia investigated, for the first time, the role of carnitine, a naturally occurring compound that is synthesized mainly in the liver, during the development of hepatocarcinogenesis.

Get the full story...

Nexavar Gets Chinese Approval For Liver Cancer Treatment

Thus, Nexavar becomes the first systemic therapy for the treatment of liver cancer as China's SFDA (U.S. version of FDA) approves Nexavar for treatment of liver cancer.

Get the full story...

Advanced liver cancer patients live longer by taking sorafenib

Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug.

Get the full story...

Combining liver cancer treatments doubles survival rates

By combining the use of stents and photodynamic therapy, also called SpyGlass, physicians at the University of Virginia have been able to significantly increase survival rates for patients suffering from advanced cholangiocarcinoma, cancer of the liver bile duct.

Get the full story...

Sunitinib may slow growth and spread of liver cancer

Treatment with sunitinib slows tumor growth and reduces the risk of metastasis in patients with hepatocellular carcinoma, an aggressive cancer of the liver, researchers report.

Get the full story...

Molecules may help predict survival in liver cancer

Tiny molecules that help cells regulate which proteins they make might one day help doctors predict which liver cancer patients are likely to live longer than others, new research suggests.

Get the full story...

Indian medicinal plant Acanthus ilicifolius may combat liver cancer

Liver cancer is the fifth most common cancer in the world with a poor prognosis. About three quarters of the cases of liver cancer are found in Southeast Asia, including China, Hong Kong, Taiwan, Korea, India, and Japan. The frequency of liver cancer in Southeast Asia and sub-Saharan Africa is greater than 20 cases per 100,000 population.

Get the full story...

Nexavar drug approved as treatment for liver cancer

The U.S. approved Nexavar drug, the product of Germany's Bayer AG, for the liver cancer treatment. The Food and Drug Administration extended the approval of the oral anticancer drug for the treatment of patients with the most common sort of liver cancer, Bayer said.

Get the full story...

Targeting nerve growth factor may cure liver cancer

Nerve growth factor (NGF), as the name says, is an essential peptide factor for the growth and differentiation of neuronal cells. Therefore we can imagine that this growth factor is important for the nervous system including brain.

Get the full story...

Targeting nerve growth factor may cure liver cancer

Nerve growth factor (NGF), as the name says, is an essential peptide factor for the growth and differentiation of neuronal cells. Therefore we can imagine that this growth factor is important for the nervous system including brain.

Get the full story...

DNA provides clues to outcome in patients with liver cancer

The main causes of liver cancer (also known as hepatocellular carcinoma [HCC]), which is the fifth most common cancer in the world, are well defined. However, the molecular pathways activated by the triggers of liver cancer are not well characterized.

Get the full story...

Molecule blocks gene, sheds light on liver cancer

New research shows how a particular small molecule blocks the activity of a cancer-suppressing gene, allowing liver-cancer cells to grow and spread.

Get the full story...